Insider · CIK 0001631746
Chas McKhann
Files at XGN (EXAGEN INC.), SILK (Silk Road Medical Inc), COCH (Envoy Medical, Inc.). First filing -, latest -.
In brief
Chas McKhann files SEC Form 4 as director and CEO at XGN (EXAGEN INC.), and also at SILK (Silk Road Medical Inc), COCH (Envoy Medical, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Chas McKhann has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | XGN EXAGEN INC. | AGrant or award Stock Option(right to buy)derivative | +37,500 | $0.00 | $0 | 45,000 | Jun 22, 2026 |
| Apr 15, 2026 | COCH Envoy Medical, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Apr 17, 2026 |
| Mar 1, 2024 | SILK Silk Road Medical Inc | AGrant or award Common Stock | +110,313 | $0.00 | $0 | 722,396 | Mar 5, 2024 |
| Nov 2, 2023 | SILK Silk Road Medical Inc | AGrant or award Common Stock | +612,083 | $0.00 | $0 | 612,083 | Nov 3, 2023 |
Questions about Chas McKhann
Answered from the filings on this page, as of the latest one.
Is Chas McKhann buying or selling?
Chas McKhann has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Chas McKhann's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Chas McKhann has 0.
Where does Chas McKhann file Form 4?
Chas McKhann has filed Form 4 at XGN (EXAGEN INC.); SILK (Silk Road Medical Inc) as Chief Executive Officer; COCH (Envoy Medical, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.